MoneyWorks4Me

Astal Laboratories - Quaterly Results

19 May 2025 Evaluate
The topline stands at Rs. 234.67 millions for the March 2025 quarter. The mentioned figure indicates a rise of about 91.54% as against Rs. 122.52 millions during the year-ago period.Net Profit for the quarter ended March 2025 zoomed to 391.76% from Rs. 5.58 millions to Rs. 27.44  millions.The company reported a good operating profit of 42.18 millions compared to 5.78 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 234.67 122.52 91.54 642.31 236.48 171.61 642.31 236.48 171.61
Other Income 0.35 0.00 0.00 1.25 0.13 861.54 1.25 0.13 861.54
PBIDT 42.18 5.78 629.76 129.02 11.28 1043.79 129.02 11.28 1043.79
Interest 2.66 0.00 0.00 7.01 0.11 6272.73 7.01 0.11 6272.73
PBDT 39.52 5.78 583.74 122.01 11.17 992.30 122.01 11.17 992.30
Depreciation 1.04 0.20 420.00 2.23 0.30 643.33 2.23 0.30 643.33
PBT 38.48 5.58 589.61 119.78 10.87 1001.93 119.78 10.87 1001.93
TAX 11.04 0.00 0.00 30.52 3.02 910.60 30.52 3.02 910.60
Deferred Tax -0.11 0.00 0.00 1.11 0.08 1287.50 1.11 0.08 1287.50
PAT 27.44 5.58 391.76 89.26 7.85 1037.07 89.26 7.85 1037.07
Equity 98.46 98.46 0.00 98.46 98.46 0.00 98.46 98.46 0.00
PBIDTM(%) 17.97 4.72 281.00 20.09 4.77 321.11 20.09 4.77 321.11
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..